Page last updated: 2024-10-31

neostigmine and Anorectal Diseases

neostigmine has been researched along with Anorectal Diseases in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dudi-Venkata, NN1
Kroon, HM1
Bedrikovetski, S1
Moore, JW1
Sammour, T1
Jennings, PJ1

Reviews

1 review available for neostigmine and Anorectal Diseases

ArticleYear
Systematic scoping review of enhanced recovery protocol recommendations targeting return of gastrointestinal function after colorectal surgery.
    ANZ journal of surgery, 2020, Volume: 90, Issue:1-2

    Topics: Bisacodyl; Chewing Gum; Colonic Diseases; Humans; Ileus; Lactulose; Neostigmine; Piperidines; Postop

2020

Other Studies

1 other study available for neostigmine and Anorectal Diseases

ArticleYear
Megarectum and megacolon in adolescents and young adults: results of treatment at St. Mark's Hospital.
    Proceedings of the Royal Society of Medicine, 1967, Volume: 60, Issue:8

    Topics: Adolescent; Adult; Colectomy; Female; Humans; Magnesium Sulfate; Male; Megacolon; Neostigmine; Recta

1967